The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong.
The Xiangtan Central Hospital, Xiangtan, Hunan.
Chest. 2020 Jul;158(1):e9-e13. doi: 10.1016/j.chest.2020.03.039. Epub 2020 Mar 31.
As of March 24, 2020, novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for 379,661 infection cases with 16,428 deaths globally, and the number is still increasing rapidly. Herein, we present four critically ill patients with SARS-CoV-2 infection who received supportive care and convalescent plasma. Although all four patients (including a pregnant woman) recovered from SARS-CoV-2 infection eventually, randomized trials are needed to eliminate the effect of other treatments and investigate the safety and efficacy of convalescent plasma therapy.
截至 2020 年 3 月 24 日，新型严重急性呼吸系统综合症冠状病毒 2（SARS-CoV-2）已在全球范围内导致 379661 例感染和 16428 例死亡，且该数字仍在迅速增加。在此，我们报告了 4 例接受支持性治疗和恢复期血浆治疗的 SARS-CoV-2 感染的重症患者。尽管所有 4 例患者（包括一名孕妇）最终均从 SARS-CoV-2 感染中康复，但仍需要开展随机试验以排除其他治疗的影响，并研究恢复期血浆治疗的安全性和疗效。
